Complement deficiencies and systemic lupus erythematosus

The complement system involves both the innate and the adaptive immune systems and has important roles in the pathogenesis of SLE. Complement deficiencies within the classical pathway (C1q, C4 and C2) of activation predispose for development of the autoimmune disease SLE. The association between complement deficiencies and SLE could be explained by several mechanisms, including impaired clearance of immune complexes and impaired handling of apoptotic cells, aberrant tolerance induction or changes in cytokine regulation. Also during SLE disease flares, the complement system is activated giving rise to partial deficiency or dysfunction due to consumption. On the other hand, complement also takes part in the inflammatory reaction in the disease that gives rise to the tissue and organ damage. In this review various aspects of the relation between complement and SLE are discussed.

[1]  L. Pillemer.  SECTION OF BIOLOGY: THE PROPERDIN SYSTEM* , 1955 .

[2]  H. Isliker,et al.  The Properdin System , 1956, Lancet.

[3]  Maddison Pj.  ANA-negative SLE. , 1982 .

[4]  V. Nussenzweig,et al.  Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus , 1982, The Journal of experimental medicine.

[5]  ANA-negative SLE. , 1982, Clinics in rheumatic diseases.

[6]  E. Brown,et al.  The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream. , 1983, Reviews of infectious diseases.

[7]  N. Hogg,et al.  Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. , 1985, Clinical and experimental immunology.

[8]  K. Steinsson,et al.  SUCCESSFUL PLASMA INFUSION TREATMENT OF A PATIENT WITH C2 DEFICIENCY AND SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL EXPERIENCE OVER FORTY‐FIVE MONTHS , 1989, Arthritis and rheumatism.

[9]  P. Densen,et al.  Infectious diseases associated with complement deficiencies , 1991, Clinical Microbiology Reviews.

[10]  M. Walport,et al.  Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. , 1992, The Journal of clinical investigation.

[11]  H. Ochs,et al.  Regulation of antibody responses: the role of complement and adhesion molecules. , 1993, Clinical Immunology and Immunopathology.

[12]  O. Nived,et al.  Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]. , 1995, The Journal of rheumatology.

[13]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[14]  Wiklund Ra,et al.  First of two parts , 1997 .

[15]  M. Botto.  C1q Knock-Out Mice for the Study of Complement Deficiency in Autoimmune Disease , 1999, Experimental and Clinical Immunogenetics.

[16]  V. Videm,et al.  Association of mannose-binding-lectin deficiency with severe atherosclerosis , 1998, The Lancet.

[17]  L. Truedsson,et al.  Properdin deficiency: molecular basis and disease association. , 1999, Molecular immunology.

[18]  M. Schwartz,et al.  Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. , 1999, The Journal of clinical investigation.

[19]  Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[20]  P. Taylor,et al.  Systemic lupus erythematosus, complement deficiency, and apoptosis. , 2000, Advances in immunology.

[21]  M. Carroll,et al.  The role of complement in B cell activation and tolerance. , 2000, Advances in immunology.

[22]  A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. , 2000 .

[23]  K. Davies,et al.  Autoantibodies to complement components. , 2000, Methods in molecular biology.

[24]  D. Lipsker,et al.  Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. , 2000, Archives of dermatology.

[25]  P. Taylor,et al.  A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.

[26]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[27]  L. Romics,et al.  Association of Chlamydia pneumoniae With Coronary Artery Disease and Its Progression Is Dependent on the Modifying Effect of Mannose-Binding Lectin , 2002, Circulation.

[28]  C. Come,et al.  Influence of C3 Deficiency on Atherosclerosis , 2002, Circulation.

[29]  C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression1 , 2002, The Journal of Immunology.

[30]  M. Walport,et al.  C1q, autoimmunity and apoptosis. , 2002, Immunobiology.

[31]  M. Walport,et al.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Rönnblom,et al.  Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity , 2003 .

[33]  L. Rönnblom,et al.  Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. , 2003, Autoimmunity.

[34]  L. Truedsson,et al.  Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility , 2004, Arthritis research & therapy.

[35]  B. Howard,et al.  Prospective Analysis of Mannose-Binding Lectin Genotypes and Coronary Artery Disease in American Indians: The Strong Heart Study , 2004, Circulation.

[36]  M. Walport,et al.  The role of complement in the development of systemic lupus erythematosus. , 2004, Annual review of immunology.

[37]  M. Carroll,et al.  A protective role for innate immunity in systemic lupus erythematosus , 2004, Nature Reviews Immunology.

[38]  Y. Matsuzawa,et al.  Complement C1q regulates LPS‐induced cytokine production in bone marrow‐derived dendritic cells , 2004, European journal of immunology.

[39]  P. Garred,et al.  Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. , 2004, The New England journal of medicine.

[40]  B. Rovin,et al.  The intricate role of complement component C4 in human systemic lupus erythematosus. , 2004, Current directions in autoimmunity.

[41]  A. Tsutsumi,et al.  Mannose binding lectin: genetics and autoimmune disease. , 2005, Autoimmunity reviews.

[42]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[43]  L. Truedsson,et al.  Complement and its breakdown products in SLE. , 2005, Rheumatology.

[44]  M. Trendelenburg.  Antibodies against C1q in patients with systemic lupus erythematosus , 2005, Springer Seminars in Immunopathology.

[45]  G. Jönsson,et al.  Hereditary C2 Deficiency in Sweden: Frequent Occurrence of Invasive Infection, Atherosclerosis, and Rheumatic Disease , 2005, Medicine.

[46]  S. Thiel,et al.  Deficiency of the mannan‐binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship , 2005, Clinical and experimental immunology.

[47]  D. Hourcade.  The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement* , 2006, Journal of Biological Chemistry.

[48]  J. Sibilia.  Treatment of systemic lupus erythematosus in 2006. , 2006, Joint, bone, spine : revue du rhumatisme.

[49]  P. Zipfel,et al.  Complement and diseases: defective alternative pathway control results in kidney and eye diseases. , 2006, Molecular immunology.

[50]  G. Jönsson,et al.  Complement deficiency and disease: an update. , 2006, Molecular immunology.

[51]  V. Pascual,et al.  Systemic lupus erythematosus: all roads lead to type I interferons. , 2006, Current opinion in immunology.

[52]  P. Garred,et al.  Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[53]  G. Jönsson,et al.  Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. , 2007, Rheumatology.

[54]  U. Kishore,et al.  Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. , 2007, Molecular immunology.

[55]  O. Nived,et al.  Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. , 2007, Rheumatology.

[56]  O. Nived,et al.  Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus , 2007, Lupus.